SNSE
Faeth Therapeutics, Inc. · HEALTHCARE
Cambrian BioPharma Inc sold $501K of Faeth Therapeutics, Inc.
10% owner
Sold$500,543
$20.02Price
25,000Shares
−16%Stake
What SNSE did after the filing
- The stock from Tue, Jun 2 open, $20.55
- +26.2%
- S&P 500, same days
- −0.8%
Measured over 30 trading days, to the Jul 16 close.
Traded Mon, Jun 1. Filed Mon, Jun 1, 5:21 PM ET, after the close. Returns use the Jun 2 open and the Jul 16 close. Not investment advice.